Download PDF
Thromb Haemost 1991; 66(03): 321-328
DOI: 10.1055/s-0038-1646415
Review Article
Schattauer GmbH Stuttgart

A Kinetic Model of the Circulatory Regulation of Tissue Plasminogen Activator

Wayne L Chandler
The Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA
› Author Affiliations
Further Information

Publication History

Received 05 November 1990

Accepted 25 February 1991

Publication Date:
25 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

A computer simulation was developed to study the regulation of active tissue plasminogen activator (t-PA) levels in plasma by kinetically modeling t-PA secretion, t-PA inhibition by plasminogen activator inhibitor type 1 (PAI-1), and hepatic clearance of t-PA, PAI-1 and t-PA/PAI-1 complex throughout a simplified human circulatory system. The model indicates that as the active PAI-1 concentration increases, the percent of t-PA in the active form decreases exponentially. Further, the reaction between t-PA and PAI-1 substantially reduces the half-lives of both active factors. By adjusting the t-PA and PAI-1 secretion rates to provide the best fit between simulated and measured circadian variations in t-PA, PAI-1 and complex, the model predicts that the diurnal rhythm in active t-PA levels is principally due to changes in the rate of PAI-1 secretion and not to variations in the t-PA secretion rate. In conclusion, the model predicts that PAI-1 is an important regulator of the concentration, half-life and circadian variation of active t-PA.

 

  • References

  • 1 Baughman RA. Pharmacokinetics of tissue plasminogen activator. In: Tissue Plasminogen Activator in Thrombolytic Therapy.. Sobel BE, Collen D, Grossbard EB. (eds) Marcel Dekker, New York: 1987. p 41
    Search in Google Scholar
  • 2 Brommer EJP, Derkx FHM, Schalekamp MADH, Dooijewaard G, Klaauw MMvd. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man. Thromb Haemostas 1988; 59: 404-11
    PubMedSearch in Google Scholar
  • 3 Keber D. Mechanism of tissue plasminogen activator release during venous occlusion. Fibrinolysis 1988; 2 (Supp 2) 96-103
    PubMedSearch in Google Scholar
  • 4 Kruithof EKO, Nicolosa G, Bachmann F. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood 1987; 70: 1645-53
    PubMedSearch in Google Scholar
  • 5 Hekman CM, Loskutoff DJ. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator. Arch Biochem Biophys 1988; 262: 199-210
    CrossrefPubMedSearch in Google Scholar
  • 6 Coleman PL, Patel PD, Cwikel BJ, Rafferty UM, Sznycer R, Gelehrter TC. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells. J Biol Chem 1986; 261: 4352-7
    PubMedSearch in Google Scholar
  • 7 Chandler WL, Schmer G, Stratton JR. Optimum conditions for the stabilization and measurement of tissue plasminogen activator in human plasma. J Lab Clin Med 1989; 113: 362-71
    PubMedSearch in Google Scholar
  • 8 Chandler WL, Loo SC, Nguyen SV, Schmer G, Stratton JR. Standardization of methods for measuring plasminogen activator inhibitor (PAI-1) activity in human plasma. Clin Chem 1989; 35: 787-93
    PubMedSearch in Google Scholar
  • 9 Chandler WL, Trimble SL, Loo SC, Mornin D. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma. Blood 1990; 76: 930-7
    PubMedSearch in Google Scholar
  • 10 Verheijen JH, Mullaart E, Chang GTG, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266-9
    PubMedSearch in Google Scholar
  • 11 Chandler WL, Mornin D, Whitten RO, Angleton P, Farin FM, Fritsche TR, Veith RC, Stratton JR. Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity. Thromb Res 1990; 58: 1-12
    CrossrefPubMedSearch in Google Scholar
  • 12 Gaffney PJ, Curtis AD. A collaborative study to establish the 2nd international standard for tissue plasminogen activator (t-PA). Thromb Haemostas 1987; 58: 1085-7
    PubMedSearch in Google Scholar
  • 13 Rånby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G. Age dependence of tissue plasminogen activator concentrations in plasma as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 1986; 32: 2160-5
    PubMedSearch in Google Scholar
  • 14 Rånby M, Nguyen G, Scarabin PY, Samama M. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Thromb Haemostas 1989; 61: 409-14
    PubMedSearch in Google Scholar
  • 15 Selkurt EE. Physiology. Little, Brown, Boston: 1976
    Search in Google Scholar
  • 16 Schmidt RF, Thews G. Human Physiology. Springer-Verlag, Berlin: 1983
    Search in Google Scholar
  • 17 van Hinsbergh VWM. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitor by endothelial cells. In: Tissue-Type Plasminogen Activator (t-PA): Physiological and Clinical Aspects.. Kluft C. (ed) CRC Press, Boca Raton, CA: 1988. 2 3-20
    Search in Google Scholar
  • 18 Krause J. Catabolism of tissue-type plasminogen activator (t-PA), its variants, mutants and hybrids. Fibrinolysis 1988; 2: 133-42
    PubMedSearch in Google Scholar
  • 19 Kruithof EKO. Plasminogen activator inhibitor type 1: biochemical, biological and clinical aspects. Fibrinolysis 1988; 2 (Suppl 2) 59-70
    PubMedSearch in Google Scholar
  • 20 Nilsson S, Einarsson S, Ekvarn S, Haggroth L, Mattsson C. Turnover of tissue plasminogen activator in normal and hepatectomized rabbits. Thromb Res 1985; 39: 511-21
    CrossrefPubMedSearch in Google Scholar
  • 21 Colucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 75: 818-24
    CrossrefPubMedSearch in Google Scholar
  • 22 Mathews JH. Numerical Methods for Computer Science, Engineering, and Mathematics. Prentice-Hall, Englewood Cliffs, NJ: 1987
    Search in Google Scholar
  • 23 Snedecor GW, Cochran WG. Statistical Methods. 17th ed. Iowa State University Press, Ames, Iowa: 1980
    Search in Google Scholar
  • 24 Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989; 79: 101-6
    CrossrefPubMedSearch in Google Scholar
  • 25 Tanswell P, Schlüter M, Krause J. Pharmacokinetics and isolated liver perfusion of carbohydrate modified recombinant tissue-type plasminogen activator. Fibrinolysis 1989; 3: 79-84
    PubMedSearch in Google Scholar